Nanomedicine applied to acute myeloid leukemia treatment via Macrophages CD44 receptors (2022)
Source: Program. Conference titles: Brazil MRS Meeting. Unidade: IFSC
Subjects: NANOCIÊNCIA, LEUCEMIA, NANOTECNOLOGIA, NEOPLASIAS, BIOMEDICINA
ABNT
ANTONIO, Luana Corsi e RIBOVSKI, Laís e ZUCOLOTTO, Valtencir. Nanomedicine applied to acute myeloid leukemia treatment via Macrophages CD44 receptors. 2022, Anais.. Rio de Janeiro: Sociedade Brasileira de Pesquisa em Materiais - SBPMat, 2022. Disponível em: https://repositorio.usp.br/directbitstream/5875bf93-e081-43ac-b0dd-8eda0590da65/3096072.pdf. Acesso em: 09 out. 2024.APA
Antonio, L. C., Ribovski, L., & Zucolotto, V. (2022). Nanomedicine applied to acute myeloid leukemia treatment via Macrophages CD44 receptors. In Program. Rio de Janeiro: Sociedade Brasileira de Pesquisa em Materiais - SBPMat. Recuperado de https://repositorio.usp.br/directbitstream/5875bf93-e081-43ac-b0dd-8eda0590da65/3096072.pdfNLM
Antonio LC, Ribovski L, Zucolotto V. Nanomedicine applied to acute myeloid leukemia treatment via Macrophages CD44 receptors [Internet]. Program. 2022 ;[citado 2024 out. 09 ] Available from: https://repositorio.usp.br/directbitstream/5875bf93-e081-43ac-b0dd-8eda0590da65/3096072.pdfVancouver
Antonio LC, Ribovski L, Zucolotto V. Nanomedicine applied to acute myeloid leukemia treatment via Macrophages CD44 receptors [Internet]. Program. 2022 ;[citado 2024 out. 09 ] Available from: https://repositorio.usp.br/directbitstream/5875bf93-e081-43ac-b0dd-8eda0590da65/3096072.pdf